Tamarack Advisers’s SomaLogic Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-20,000
Closed -$51K – 49
2023
Q1
$51K Buy
+20,000
New +$8.79K 0.02% 39
2022
Q4
– Sell
-20,000
Closed -$9K – 50
2022
Q3
$9K Hold
20,000
– – 0.01% 46
2022
Q2
$15K Buy
+20,000
New +$22.7K 0.01% 41
2022
Q1
– Sell
-20,000
Closed -$67K – 61
2021
Q4
$67K Hold
20,000
– – 0.03% 46
2021
Q3
$69K Buy
+20,000
New +$61.6K 0.02% 43

Other funds holding SLGCW

Tamarack Advisers's SLGCW Position: Q2 2023 in Review

Tamarack Advisers sold out of SomaLogic Warrant (SLGCW) in Q2 2023, closing a stake of 20,000 shares — an estimated $51K sold.

Tamarack Advisers first reported a position in SLGCW in Q3 2021 and held it in 5 quarters. The position peaked at $69K in Q3 2021. 21 funds tracked by Wall St. Rank hold SLGCW as of Q2 2023.

  • Tamarack Advisers reported no remaining SomaLogic Warrant position as of Q2 2023 after selling out during the quarter.
  • Tamarack Advisers sold 20,000 SomaLogic Warrant shares in Q2 2023, an estimated $51K.
  • Tamarack Advisers first reported a position in SomaLogic Warrant in Q3 2021 and held it in 5 quarters.
  • Tamarack Advisers's SomaLogic Warrant position peaked at $69K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held SomaLogic Warrant as of Q2 2023.

Based on Tamarack Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.